Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 3CO3.2Al |
| Molecular Weight | 233.9898 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Al+3].[Al+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O
InChI
InChIKey=PPQREHKVAOVYBT-UHFFFAOYSA-H
InChI=1S/3CH2O3.2Al/c3*2-1(3)4;;/h3*(H2,2,3,4);;/q;;;2*+3/p-6
| Molecular Formula | CO3 |
| Molecular Weight | 60.0089 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Al |
| Molecular Weight | 26.9815 |
| Charge | 3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Potash (Dihydroxyaluminum Sodium Carbonate), a component of
Kompensan-S Forte in Germany, is a basic inorganic salt that acts by neutralizing hydrochloric acid in gastric secretions. Kompensan-S Forte is slowly solubilized in the stomach and reacts with hydrochloric acid to form aluminum chloride and water. It also inhibits the action of pepsin by increasing the pH and via adsorption. Cytoprotective effects may occur through increases in bicarbonate ion (HCO3-) and prostaglandins.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL261 |
|||
Target ID: CHEMBL205 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Kompensan Approved UseGastrointestinal disorders: Dyspepsia, Duodenal Ulcer, Erosive Esophagitis, Gastric Ulcer, Gastroesophageal Reflux Disease, Zollinger-Ellison Syndrome, Hyperphosphatemia |
Sample Use Guides
Usual Adult Dose for Dyspepsia: 500 to 600 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Duodenal Ulcer: 500 to 1500 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Erosive Esophagitis: 500 to 1500 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Gastric Ulcer: 500 to 1500 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Gastroesophageal Reflux Disease: 500 to 1500 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Zollinger-Ellison Syndrome: 500 to 3600 mg orally 4 to 6 times a day as needed, between meals and at bedtime. Usual Adult Dose for Hyperphosphatemia: 500 to 1000 mg orally 4 times a day, with meals and at bedtime. The dosage should be titrated to the serum phosphate level.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:55:09 GMT 2023
by
admin
on
Fri Dec 15 18:55:09 GMT 2023
|
| Record UNII |
1GA689N629
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 331.11
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
14455-29-9
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
PRIMARY | |||
|
ALUMINIUM CARBONATE
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
PRIMARY | |||
|
4526
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
PRIMARY | |||
|
210894-13-6
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
SUPERSEDED | |||
|
CHEMBL2109015
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
PRIMARY | |||
|
SUB12815MIG
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
PRIMARY | |||
|
1GA689N629
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
PRIMARY | |||
|
89858
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
PRIMARY | |||
|
53547-27-6
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
SUPERSEDED | |||
|
DTXSID30891680
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
CONCEPT | Industrial Aid | ||
|
1GA689N629
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
PRIMARY | |||
|
100000077670
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
PRIMARY | |||
|
238-440-2
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
PRIMARY | |||
|
C120559
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
PRIMARY | |||
|
C025173
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
PRIMARY | |||
|
10353966
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
PRIMARY | |||
|
18789
Created by
admin on Fri Dec 15 18:55:09 GMT 2023 , Edited by admin on Fri Dec 15 18:55:09 GMT 2023
|
ALTERNATIVE |